{
  "id": 101159,
  "name": "HILL-ROM",
  "slug": "hill-rom",
  "state": "DC",
  "description": "Medical device manufacturer",
  "totalSpending": 1490000,
  "filings": 12,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 540000
    },
    {
      "year": 2019,
      "income": 560000
    },
    {
      "year": 2020,
      "income": 340000
    },
    {
      "year": 2021,
      "income": 50000
    }
  ],
  "firms": [
    "AKIN GUMP STRAUSS HAUER & FELD"
  ],
  "lobbyists": [
    "MARTHA KENDRICK",
    "KENDALL HUSSEY",
    "HEIDE BAJNRAUH",
    "BETH COLLINS",
    "LOUIS AGNELLO",
    "GORDON BATES",
    "MATTHEW TUTEN",
    "JEFF MCMILLEN"
  ],
  "issues": [
    "BUD",
    "TAX",
    "HCR",
    "VET",
    "MMM"
  ],
  "sampleDescriptions": [
    "Diabetic retinopathy.",
    "Medical Device excise tax repeal; taxation of medical technology; R & D tax credit; corporate tax reform.",
    "Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018.",
    "VA Procurement and payment reforms; prompt pay, veterans choice program issues, Care Veterans Deserve Act (H.R. 1152).",
    "Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2015 (H.R. 184/S. 108); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform, diabetic retinopathy; Extension of Continuing Appropriations Act of 2018; Bipartisan Budget Act of 2018.",
    "Medical Device excise tax repeal (H.R. 184); taxation of medical technology; R & D tax credit; corporate tax reform.",
    "Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 1041/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018; H.R.6639 Diabetic Retinopothy Vision Loss and Blindness Prevention Act of 2018",
    "Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2015 (H.R. 184/S. 108); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform, H.R.6639 Diabetic retinopothy Vision Loss and Blindness Prevention Act of 2018; Extension of Continuing Appropriations Act of 2018; Bipartisan Budget Act of 2018.",
    "Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (H.R. 184/S. 108); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018; H.R.6639 Diabetic Retinopothy Vision Loss and Blindness Prevention Act of 2018",
    "VA Procurement and payment reforms; prompt pay, veterans choice program issues.",
    "Medical Device excise tax repeal (H.R. 2207, S.692); taxation of medical technology.",
    "Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act\n(H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (S. 692, H.R. 2207); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe\npatient handling, FDA reform.",
    "Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2019 (H.R. 2207/S. 692); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018.",
    "Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (S. 692, H.R. 2207); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); Sepsis funding and education.",
    "Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2019 (H.R. 2207/S. 692); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018. Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); Sepsis funding and education.",
    "Medical Device excise tax repeal (H.R. 2207, S.692); taxation of medical technology; Further Consolidated Appropriations Act, 2020, (H.R.1865).",
    "Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (S. 692, H.R. 2207); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).",
    "Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2019 (H.R. 2207/S. 692); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018. Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).",
    "COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Sec. S965 and GILTI.",
    "COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254)."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021
  ],
  "growthRate": -91,
  "trajectory": "declining",
  "yearsActive": 4,
  "avgAnnualSpending": 372500,
  "peakYear": 2019,
  "lobbyistCount": 8,
  "firmCount": 1,
  "issueCount": 5
}